Evidence map›Paper›PMID 10580638›Full record

ReviewImmunologic research1999

Regulation of integrin function by T cell activation: points of convergence and divergence.

T Zell, W J Kivens, S A Kellermann, Y Shimizu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 25 citations in OpenAlex.

  1. Impairment of immunological synapse formation in adaptively tolerant T cells.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
  2. Article
  3. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.Matrix biology : journal of the International Society for Matrix Biology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

T ZellDepartment of Laboratory Medicine and Pathology, Center for Immunology, Cancer Center, University of Minnesota Medical School, Minneapolis, USA.
W J Kivens
S A Kellermann
Y Shimizu
University of Minnesota Medical Center · USMedtronic (Ireland) · IE

Funding

STRUCTURE/FUNCTION ANALYSIS OF T CELL BETA1 INTEGRINR01AI038474 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1995 to 2014
$4.7M
Very Late Antigen Integrin Activity on T CellsR01AI031126 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1996 to 2010
$3.7M
Adapter proteins and integrin functionR56AI038474 · NIAID · UNIVERSITY OF MINNESOTA · PI SHIMIZU, YOJI · 2010 to 2010
$108k
REGULATION OF VLA INTEGRIN FUNCTION ON T-CELLSR29AI031126 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1991 to 1995
–
NIAID NIH HHS AI31126NIAID NIH HHS AI38474NIAMS NIH HHS F32-AR09438
6 · The paper itself

Abstract

Lymphocyte adhesiveness is dynamically regulated in response to conditions in the extracellular environment. One mechanism of regulation of integrin adhesion receptors involves a rapid, but transient, increase in integrin function upon T lymphocyte activation. These integrin activating signals can be initiated either via ligation of Ig superfamily members that are coupled to tyrosine kinase cascades, such as the CD3/T cell receptor, CD2, and CD28, or by G protein-coupled receptors for chemokines. Analysis of integrin activation induced by CD3/TCR, CD2 and CD28 suggests a critical role for phosphoinositide 3-OH kinase (PI 3-K). This review summarizes recent insights into PI 3-K-dependent regulation of integrin function in leukocytes, including the mechanisms by which these receptors are coupled to PI 3-K, and potential downstream effectors of PI 3-K that regulate integrin-mediated adhesion in leukocytes.

Indexed as

AnimalsCD28 AntigensCD2 AntigensCell AdhesionHumansIntegrinsLymphocyte ActivationPhosphatidylinositol 3-KinasesReceptor-CD3 Complex, Antigen, T-CellSignal TransductionT-LymphocytesUp-RegulationCD28 AntigensCD2 AntigensIntegrinsPhosphatidylinositol 3-KinasesReceptor-CD3 Complex, Antigen, T-Cell

Identifiers

PMID10580638
OpenAlexW2334048540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.